163 related articles for article (PubMed ID: 34411614)
1. Chitosan modified squalene nanostructured lipid carriers as a promising adjuvant for freeze-dried ovalbumin vaccine.
Gao X; Gong J; Cai Y; Wang J; Wen J; Peng L; Ji H; Jiang S; Guo D
Int J Biol Macromol; 2021 Oct; 188():855-862. PubMed ID: 34411614
[TBL] [Abstract][Full Text] [Related]
2. Cationic polymer modified PLGA nanoparticles encapsulating Alhagi honey polysaccharides as a vaccine delivery system for ovalbumin to improve immune responses.
Wusiman A; Gu P; Liu Z; Xu S; Zhang Y; Hu Y; Liu J; Wang D; Huang X
Int J Nanomedicine; 2019; 14():3221-3234. PubMed ID: 31123399
[No Abstract] [Full Text] [Related]
3. Tailoring nanostructured lipid carriers for the delivery of protein antigens: Physicochemical properties versus immunogenicity studies.
Courant T; Bayon E; Reynaud-Dougier HL; Villiers C; Menneteau M; Marche PN; Navarro FP
Biomaterials; 2017 Aug; 136():29-42. PubMed ID: 28511142
[TBL] [Abstract][Full Text] [Related]
4. pH Sensitive phosphorylated chitosan hydrogel as vaccine delivery system for intramuscular immunization.
Wei J; Xue W; Yu X; Qiu X; Liu Z
J Biomater Appl; 2017 May; 31(10):1358-1369. PubMed ID: 28387574
[TBL] [Abstract][Full Text] [Related]
5. Lignin nanoparticles as a promising vaccine adjuvant and delivery system for ovalbumin.
Alqahtani MS; Kazi M; Ahmad MZ; Syed R; Alsenaidy MA; Albraiki SA
Int J Biol Macromol; 2020 Nov; 163():1314-1322. PubMed ID: 32645499
[TBL] [Abstract][Full Text] [Related]
6. In vivo investigation of twin-screw extruded lipid implants for vaccine delivery.
Even MP; Young K; Winter G; Hook S; Engert J
Eur J Pharm Biopharm; 2014 Jul; 87(2):338-46. PubMed ID: 24607791
[TBL] [Abstract][Full Text] [Related]
7. Resveratrol: Isolation, and Its Nanostructured Lipid Carriers, Inhibits Cell Proliferation, Induces Cell Apoptosis in Certain Human Cell Lines Carcinoma and Exerts Protective Effect Against Paraquat-Induced Hepatotoxicity.
Elgizawy HA; Ali AA; Hussein MA
J Med Food; 2021 Jan; 24(1):89-100. PubMed ID: 32580673
[TBL] [Abstract][Full Text] [Related]
8. Preparation and characterization of dutasteride-loaded nanostructured lipid carriers coated with stearic acid-chitosan oligomer for topical delivery.
Noor NM; Sheikh K; Somavarapu S; Taylor KMG
Eur J Pharm Biopharm; 2017 Aug; 117():372-384. PubMed ID: 28412472
[TBL] [Abstract][Full Text] [Related]
9. Squalene containing solid lipid nanoparticles, a promising adjuvant system for yeast vaccines.
Stelzner JJ; Behrens M; Behrens SE; Mäder K
Vaccine; 2018 Apr; 36(17):2314-2320. PubMed ID: 29567034
[TBL] [Abstract][Full Text] [Related]
10. The pH-sensitive fusogenic 3-methyl-glutarylated hyperbranched poly(glycidol)-conjugated liposome induces antigen-specific cellular and humoral immunity.
Hebishima T; Yuba E; Kono K; Takeshima SN; Ito Y; Aida Y
Clin Vaccine Immunol; 2012 Sep; 19(9):1492-8. PubMed ID: 22815149
[TBL] [Abstract][Full Text] [Related]
11. Non-invasive delivery of nanoparticles to hair follicles: a perspective for transcutaneous immunization.
Mittal A; Raber AS; Schaefer UF; Weissmann S; Ebensen T; Schulze K; Guzmán CA; Lehr CM; Hansen S
Vaccine; 2013 Jul; 31(34):3442-51. PubMed ID: 23290836
[TBL] [Abstract][Full Text] [Related]
12. Freeze-drying of ovalbumin loaded mesoporous silica nanoparticle vaccine formulation increases antigen stability under ambient conditions.
Mody KT; Mahony D; Cavallaro AS; Stahr F; Qiao SZ; Mahony TJ; Mitter N
Int J Pharm; 2014 Apr; 465(1-2):325-32. PubMed ID: 24583208
[TBL] [Abstract][Full Text] [Related]
13. A comparison of the immune responses induced by antigens in three different archaeosome-based vaccine formulations.
Jia Y; Akache B; Deschatelets L; Qian H; Dudani R; Harrison BA; Stark FC; Chandan V; Jamshidi MP; Krishnan L; McCluskie MJ
Int J Pharm; 2019 Apr; 561():187-196. PubMed ID: 30836154
[TBL] [Abstract][Full Text] [Related]
14. Angelica sinensis polysaccharide encapsulated into PLGA nanoparticles as a vaccine delivery and adjuvant system for ovalbumin to promote immune responses.
Gu P; Liu Z; Sun Y; Ou N; Hu Y; Liu J; Wu Y; Wang D
Int J Pharm; 2019 Jan; 554():72-80. PubMed ID: 30399435
[TBL] [Abstract][Full Text] [Related]
15. Comparison of chitosan nanoparticles and chitosan hydrogels for vaccine delivery.
Gordon S; Saupe A; McBurney W; Rades T; Hook S
J Pharm Pharmacol; 2008 Dec; 60(12):1591-600. PubMed ID: 19000363
[TBL] [Abstract][Full Text] [Related]
16. Curdlan sulfate-
Zhang S; Huang S; Lu L; Song X; Li P; Wang F
Int J Nanomedicine; 2018; 13():2377-2394. PubMed ID: 29713168
[TBL] [Abstract][Full Text] [Related]
17. Antigen-conjugated N-trimethylaminoethylmethacrylate chitosan nanoparticles induce strong immune responses after nasal administration.
Liu Q; Zheng X; Zhang C; Shao X; Zhang X; Zhang Q; Jiang X
Pharm Res; 2015 Jan; 32(1):22-36. PubMed ID: 24970313
[TBL] [Abstract][Full Text] [Related]
18. Development of a novel vaccine delivery system based on Gantrez nanoparticles.
Gómez S; Gamazo C; San Roman B; Vauthier C; Ferrer M; Irachel JM
J Nanosci Nanotechnol; 2006; 6(9-10):3283-9. PubMed ID: 17048548
[TBL] [Abstract][Full Text] [Related]
19. Enhanced mucosal and systemic immune response with squalane oil-containing multiple emulsions upon intranasal and oral administration in mice.
Shahiwala A; Amiji MM
J Drug Target; 2008 May; 16(4):302-10. PubMed ID: 18446609
[TBL] [Abstract][Full Text] [Related]
20. Mucosal and systemic immune responses by intranasal immunization using archaeal lipid-adjuvanted vaccines.
Patel GB; Zhou H; Ponce A; Chen W
Vaccine; 2007 Dec; 25(51):8622-36. PubMed ID: 17959279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
